ZNF207 Antibody (A-7): sc-271277
- ZNF207 Antibody (A-7) is a mouse monoclonal IgG1 κ provided at 200 µg/ml
- raised against amino acids 1-184 mapping at the N-terminus of ZNF207 of human origin
- recommended for detection of ZNF207 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA
- m-IgG Fc BP-HRP, m-IgG1 BP-HRP and m-IgGκ BP-HRP are the preferred secondary detection reagents for ZNF207 Antibody (A-7) for WB and IHC(P) applications. These reagents are now offered in bundles with ZNF207 Antibody (A-7) (see ordering information below).
QUICK LINKS
SEE ALSO...
ZNF207 Antibody (A-7) is a mouse monoclonal IgG1 antibody that detects ZNF207 in mouse, rat, and human samples through various applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry, and enzyme-linked immunosorbent assay (ELISA). ZNF207, a 478 amino acid protein, is primarily localized in the nucleus and is characterized by the presence of two C2H2-type zinc finger domains, which are crucial for its role as a transcription factor. ZNF207 (A-7) antibody recognizes a protein that binds DNA through these zinc fingers to regulate gene expression, making ZNF207 an important player in cellular processes such as development, differentiation, and response to environmental signals. Anti-ZNF207 antibody (A-7) targets a protein that is expressed ubiquitously across tissues, with three isoforms resulting from alternative splicing events. Understanding ZNF207′s role in transcriptional regulation is vital, as dysregulation of zinc-finger proteins has been implicated in various diseases, including cancer, highlighting the significance of ZNF207 monoclonal antibody (A-7) in research and diagnostic applications.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
ZNF207 Antibody (A-7) References:
- Oncogenic HER2 fusions in gastric cancer. | Yu, DH., et al. 2015. J Transl Med. 13: 116. PMID: 25889497
- A distinct isoform of ZNF207 controls self-renewal and pluripotency of human embryonic stem cells. | Fang, F., et al. 2018. Nat Commun. 9: 4384. PMID: 30349051
- [Expression of ZNF207 in hepatocellular carcinoma and its significance]. | Zhou, C. and Li, N. 2019. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 44: 406-412. PMID: 31113916
- System analysis based on the cancer-immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma. | Wang, X., et al. 2022. J Immunother Cancer. 10: PMID: 35246476
- Identification of Potential Diagnostic Genes of HIV-Infected Immunological Non-Responders on Bioinformatics Analysis. | Ding, Y., et al. 2023. J Inflamm Res. 16: 1555-1570. PMID: 37082297
- Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. | Wang, H., et al. 2023. Front Immunol. 14: 1291859. PMID: 38143740
- Discovery of Novel N-(Anthracen-9-ylmethyl) Benzamide Derivatives as ZNF207 Inhibitors Promising in Treating Glioma. | Zhang, M., et al. 2024. J Med Chem. 67: 3909-3934. PMID: 38377560
- Zinc finger Protein207 orchestrates glioma migration through regulation of epithelial-mesenchymal transition. | Zhao, C., et al. 2024. Environ Toxicol.. PMID: 38591780
- Pan-cancer bioinformatics indicates zinc finger protein 207 is a promising prognostic biomarker and immunotherapeutic target. | Hu, Q., et al. 2024. J Leukoc Biol. 117: PMID: 38970506
- ZNF207, a ubiquitously expressed zinc finger gene on chromosome 6p21.3. | Pahl, PM., et al. 1998. Genomics. 53: 410-2. PMID: 9799612
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ZNF207 Antibody (A-7) | sc-271277 | 200 µg/ml | $322.00 | |||
ZNF207 Antibody (A-7): m-IgG Fc BP-HRP Bundle | sc-537602 | 200 µg Ab; 10 µg BP | $361.00 | |||
ZNF207 Antibody (A-7): m-IgGκ BP-HRP Bundle | sc-534913 | 200 µg Ab; 40 µg BP | $361.00 | |||
ZNF207 Antibody (A-7): m-IgG1 BP-HRP Bundle | sc-545255 | 200 µg Ab; 20 µg BP | $361.00 |